Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
CDT Equity Inc. (CDT)
USD0.35
+0.00 (+0.29%)
US NASDAQ Healthcare Biotechnology
Address
4581 Tamiami Trail North 34103
Naples, FL, US
Naples, FL, US
CEO
Andrew Regan
Website
conduitpharma.com
IPO
2022-03-28
CIK 1896212 ISIN US20678X5023
Also trades on
NASDAQ Capital Market · CDTTW (USD)
NASDAQ Global Market · CDT (USD)
NASDAQ Global Market · MURF (USD)
NASDAQ Global Market · MURFU (USD)
NASDAQ Global Market · MURFW (USD)
Description
Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.35
+0.00 (+0.29%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
7M
Beta
1.46
Float Shares
73.0K
Free Float %
41.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.80% | -19.00% | -42.78% | -93.20% | -96.38% | -92.94% | -99.85% | -100.00% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.35
DCF (Unlevered)
1,980,566.46
+564,263,848.5%
DCF (Levered)
1,098,561.99
+312,980,524.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Quality scores
Altman Z-Score
1.08
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
3 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
2 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+128.8% ★ Q1'26: +100.4% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+11.0% Q1'26: -9.1% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+11.7% ★ Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+13.1% ★ Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+1,847.3% Q1'26: +482,161.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×3.46× Q1'26: 4.33× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | B | 3/5 | 2/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 2/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-21 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-20 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
97.72M
OE per share TTM
-9.16
Owner's Yield
111.40%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
0.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
1
Beneficial owners (>5%)
23
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Andrew Regan | 30.29M | 31.56% | 66.7K | 30.23M | 66.7K | 30.23M | IN | British | 2024-09-19 | ↗ |
| 2 | Corvus Capital Ltd. | 30.05M | 31.30% | — | 30.05M | — | 30.05M | CO | Islands | 2024-09-19 | ↗ |
| 3 | Limited | 8.09M | 8.30% | — | 8.09M | — | 8.09M | CO | Guernsey | 2024-10-07 | ↗ |
| 4 | Rowland Master Trust | 8.09M | 8.30% | — | 8.09M | — | 8.09M | OO | Guernsey | 2024-10-07 | ↗ |
| 5 | St George Street Capital | 4.75M | 6.60% | 4.75M | — | 4.75M | — | OO | England and Wales | 2023-09-29 | ↗ |
| 6 | Abigail P. Johnson | 4.49M | 10.99% | — | — | 4.49M | — | IN | Delaware | 2024-10-07 | ↗ |
| 7 | FMR LLC | 4.49M | 10.99% | 4.48M | — | 4.49M | — | HC | Delaware | 2024-10-07 | ↗ |
| 8 | Canyon Acquisition Sponsor, LLC | 4.06M | 23.49% | 4.06M | — | 4.06M | — | OO | or Place of Organization | 2022-02-14 | ↗ |
| 9 | K. Heilbron | 4.06M | 23.49% | — | 4.06M | — | 4.06M | IN | or Place of Organization | 2022-02-14 | ↗ |
| 10 | Wellington Group Holdings LLP | 2.13M | 5.23% | — | 1.54M | — | — | HC | Delaware | 2024-11-08 | ↗ |
| 11 | Wellington Investment Advisors Holdings LLP | 2.13M | 5.23% | — | 1.54M | — | — | HC | Delaware | 2024-11-08 | ↗ |
| 12 | Wellington Management Group LLP | 2.13M | 5.23% | — | 1.54M | — | — | HC | Massachusetts | 2024-11-08 | ↗ |
| 13 | Hudson Bay Capital Management LP | 934.1K | 6.68% | — | 934.1K | — | — | PN | State of Delaware | 2023-02-10 | ↗ |
| 14 | Sander Gerber | 934.1K | 6.68% | — | 934.1K | — | — | IN | State of Delaware | 2023-02-10 | ↗ |
| 15 | Boaz R. Weinstein | 765.0K | 5.50% | — | 765.0K | — | 765.0K | IN | Citizenship or Place of Organization | 2022-02-11 | ↗ |
| 16 | Saba Capital Management GP, LLC | 765.0K | 5.50% | — | 765.0K | — | 765.0K | OO | Citizenship or Place of Organization | 2022-02-11 | ↗ |
| 17 | Saba Capital Management, L.P. | 765.0K | 5.50% | — | 765.0K | — | 765.0K | IA, PN | Citizenship or Place of Organization | 2022-02-11 | ↗ |
| 18 | Space Summit Capital LLC | 727.3K | 6.32% | 727.3K | — | 727.3K | — | IA | Delaware | 2022-02-04 | ↗ |
| 19 | MM Asset Management Inc. | 700.0K | 6.10% | — | 700.0K | — | 700.0K | CO | — | 2022-02-10 | ↗ |
| 20 | MMCAP International Inc. SPC | 700.0K | 6.10% | — | 700.0K | — | 700.0K | CO | — | 2022-02-10 | ↗ |
| 21 | Polar Asset Management Partners Inc. | 700.0K | 5.01% | 700.0K | — | 700.0K | — | IA | Ontario, Canada | 2023-02-10 | ↗ |
| 22 | Shaolin Capital Management, LLC | 609.8K | 20.73% | 609.8K | — | 609.8K | — | OO | or Place of Organization | 2023-02-16 | ↗ |
| 23 | Algo Holdings, Inc. | 177.6K | 0.19% | — | 177.6K | — | 177.6K | CO | Delaware | 2024-09-19 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
7
Sells
0
Shares acquired
630.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+630,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | Olsen Ulrik K | Director | — | — | Common Stock | 0 | 0.00 | — | 233,585 | D | ↗ |
| 2026-03-17 | Taylor Mark Andrew | 10% Owner | J-Other | A | Common Stock | 51,420,358 | 0.00 | — | 51,700,014 | I | ↗ |
| 2026-02-19 | Taylor Mark Andrew | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 325,958 | I | ↗ |
| 2026-02-19 | Farley Chele Chiavacci | Director | A-Award | A | Common Stock | 10,553 | 1.04 | 11.0K | 17,157 | D | ↗ |
| 2025-12-08 | Regan Andrew | Director / Officer / 10% Owner | A-Award | A | Pre-Funded Warrants | 3,685,815 | 0.00 | 368.58 | 3,685,815 | I | ↗ |
| 2025-09-19 | Regan Andrew | Director / Officer / 10% Owner | A-Award | A | Common Stock | 1,120,000 | 0.69 | 768.7K | 1,120,044 | D | ↗ |
| 2025-09-19 | Bligh James | Director / Officer | A-Award | A | Common Stock | 480,000 | 0.00 | — | 480,024 | D | ↗ |
| 2025-08-12 | Lewis-Hall Freda C | Director | A-Award | A | Common Stock | 35,000 | 0.00 | — | 38,466 | D | ↗ |
| 2025-08-12 | Fry Simon Jeremy | Director | A-Award | A | Common Stock | 35,000 | 0.00 | — | 36,956 | D | ↗ |
| 2025-08-12 | Farley Chele Chiavacci | Director | A-Award | A | Common Stock | 35,000 | 0.00 | — | 37,369 | D | ↗ |
| 2025-08-05 | Lewis-Hall Freda C | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 1.89 | 28.4K | 15,000 | D | ↗ |
| 2025-08-05 | Fry Simon Jeremy | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 1.89 | 28.4K | 15,000 | D | ↗ |
| 2025-08-05 | Farley Chele Chiavacci | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 1.89 | 28.4K | 15,000 | D | ↗ |
| 2025-06-03 | Regan Andrew | Director / Officer / 10% Owner | A-Award | A | Common Stock | 154,799 | 3.23 | 500.0K | 154,799 | I | ↗ |
| 2025-04-16 | Charles Faith L. | Director | A-Award | A | Common Stock | 115,194 | 0.87 | 100.0K | 165,238 | D | ↗ |
| 2025-03-31 | Sarborg Ltd | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 1,853,933 | D | ↗ |
| 2025-03-30 | Lewis-Hall Freda C | Director | A-Award | A | Common Stock | 47,612 | 0.89 | 42.4K | 51,991 | D | ↗ |
| 2025-03-30 | Fry Simon Jeremy | Director | A-Award | A | Common Stock | 29,354 | 0.89 | 26.1K | 31,354 | D | ↗ |
| 2025-03-30 | Farley Chele Chiavacci | Director | A-Award | A | Common Stock | 32,022 | 0.89 | 28.5K | 35,537 | D | ↗ |
| 2025-03-30 | Charles Faith L. | Director | A-Award | A | Common Stock | 46,629 | 0.89 | 41.5K | 50,044 | D | ↗ |
| 2024-12-18 | Lewis-Hall Freda C | Director | A-Award | A | Stock Option (Right to Buy) | 420,000 | 0.07 | 29.8K | 420,000 | D | ↗ |
| 2024-12-18 | Fry Simon Jeremy | Director | A-Award | A | Stock Option (Right to Buy) | 420,000 | 0.07 | 29.8K | 420,000 | D | ↗ |
| 2024-12-18 | Farley Chele Chiavacci | Director | A-Award | A | Stock Option (Right to Buy) | 420,000 | 0.07 | 29.8K | 420,000 | D | ↗ |
| 2024-12-18 | Charles Faith L. | Director | A-Award | A | Stock Option (Right to Buy) | 420,000 | 0.07 | 29.8K | 420,000 | D | ↗ |
| 2024-11-18 | Tapolczay David | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 840,000 | 0.09 | 77.2K | 840,000 | D | ↗ |
| 2024-11-18 | Lewis-Hall Freda C | Director | A-Award | A | Common Stock | 437,976 | 0.09 | 40.2K | 437,976 | D | ↗ |
| 2024-11-18 | Farley Chele Chiavacci | Director | A-Award | A | Common Stock | 299,238 | 0.09 | 27.5K | 351,510 | D | ↗ |
| 2024-11-18 | Charles Faith L. | Director | A-Award | A | Common Stock | 75,000 | 0.00 | — | 75,000 | D | ↗ |
| 2024-11-18 | Bligh James | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 1,890,000 | 0.09 | 173.7K | 1,890,000 | D | ↗ |
| 2024-10-07 | Nirland Ltd | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 939,009 | 0.10 | 96.5K | 6,092,000 | D | ↗ |
| 2024-10-04 | Nirland Ltd | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 1,368,991 | 0.10 | 140.5K | 7,031,009 | D | ↗ |
| 2024-10-03 | Nirland Ltd | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 1,500,000 | 0.10 | 156.5K | 8,400,000 | D | ↗ |
| 2024-10-02 | Nirland Ltd | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 333,177 | 0.10 | 34.3K | 9,900,000 | D | ↗ |
| 2024-10-01 | Nirland Ltd | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 1,250,000 | 0.11 | 141.4K | 10,233,177 | D | ↗ |
| 2024-09-30 | Nirland Ltd | 10% Owner | S-Sale | D | Common Stock, par value $0.0001 per share | 1,016,823 | 0.12 | 122.0K | 11,483,177 | D | ↗ |
| 2024-08-06 | Nirland Ltd | 10% Owner | — | D | Common Stock Warrant | 2,000,000 | 11.50 | 23.00M | 0 | — | ↗ |
| 2024-07-17 | Regan Andrew | Director / 10% Owner | S-Sale | D | Common Stock | 1,514,100 | 0.26 | 391.1K | 177,627 | — | ↗ |
| 2024-07-16 | Regan Andrew | Director / 10% Owner | S-Sale | D | Common Stock | 10,244,392 | 0.32 | 3.25M | 1,691,727 | — | ↗ |
| 2024-07-15 | Regan Andrew | Director / 10% Owner | S-Sale | D | Common Stock | 1,005,200 | 0.25 | 248.4K | 11,936,119 | — | ↗ |
| 2024-07-12 | Regan Andrew | Director / 10% Owner | S-Sale | D | Common Stock | 1,389,820 | 0.25 | 343.4K | 12,941,319 | — | ↗ |
| 2024-07-11 | Regan Andrew | Director / 10% Owner | S-Sale | D | Common Stock | 300,000 | 0.29 | 87.0K | 14,331,139 | — | ↗ |
| 2024-07-10 | Regan Andrew | Director / 10% Owner | S-Sale | D | Common Stock | 150,000 | 0.33 | 50.1K | 15,214,091 | — | ↗ |
| 2024-07-09 | Regan Andrew | Director / 10% Owner | S-Sale | D | Common Stock | 77,681 | 0.44 | 33.9K | 15,364,091 | — | ↗ |
| 2024-07-08 | Regan Andrew | Director / 10% Owner | S-Sale | D | Common Stock | 35,923 | 0.51 | 18.3K | 15,441,772 | — | ↗ |
| 2024-07-03 | Regan Andrew | Director / 10% Owner | S-Sale | D | Common Stock | 1,000 | 0.64 | 640.00 | 15,477,695 | — | ↗ |
| 2024-06-14 | Regan Andrew | Director / 10% Owner | J-Other | A | Common Stock | 1,100,000 | 0.00 | 110.00 | 15,478,695 | — | ↗ |
| 2024-06-11 | Farley Chele Chiavacci | Director | A-Award | A | Common Stock | 37,272 | 0.00 | — | 52,272 | — | ↗ |
| 2024-06-11 | Bligh James | Director / Officer | A-Award | A | Common Stock | 37,272 | 0.00 | — | 37,272 | — | ↗ |
| 2024-05-15 | Sragovicz Adam | Officer | D-Return | D | Restricted Stock Units | 74,545 | 0.00 | — | 0 | — | ↗ |
| 2024-05-13 | McNealey Jennifer Isacoff | Director | D-Return | D | Stock Option (Right to Buy) | 65,000 | 5.51 | 358.2K | 0 | — | ↗ |
| 2024-04-22 | Tapolczay David | Director / Officer | S-Sale | D | Warrant (Right to buy) | 200,332 | 3.12 | 625.0K | 200,332 | — | ↗ |
| 2024-04-22 | Lewis-Hall Freda C | Director | A-Award | A | Warrant (Right to buy) | 400,664 | 3.12 | 1.25M | 400,664 | — | ↗ |
| 2024-04-22 | Farley Chele Chiavacci | Director | P-Purchase | A | Warrant (Right to buy) | 200,332 | 3.12 | 625.0K | 203,332 | — | ↗ |
| 2023-12-01 | Tapolczay David | Director | A-Award | A | Stock Option (Right to Buy) | 298,179 | 5.51 | 1.64M | 298,179 | — | ↗ |
| 2023-12-01 | Sragovicz Adam | Officer | A-Award | A | Restricted Stock Units | 74,545 | 0.00 | — | 74,545 | — | ↗ |
| 2023-12-01 | McNealey Jennifer Isacoff | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 5.51 | 358.2K | 65,000 | — | ↗ |
| 2023-12-01 | Lewis-Hall Freda C | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 5.51 | 358.2K | 65,000 | — | ↗ |
| 2023-12-01 | Farley Chele Chiavacci | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 5.51 | 358.2K | 65,000 | — | ↗ |
| 2023-12-01 | Charles Faith L. | Director | A-Award | A | Stock Option (Right to Buy) | 65,000 | 5.51 | 358.2K | 65,000 | — | ↗ |
| 2023-12-01 | Bligh James | Director | A-Award | A | Stock Option (Right to Buy) | 223,634 | 5.51 | 1.23M | 223,634 | — | ↗ |
| 2023-09-22 | Tapolczay David | Director / Officer | — | D | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 2,003,324 | — | ↗ |
| 2023-09-22 | Regan Andrew | Director / 10% Owner | — | I | Shares | 0 | 0.00 | — | 45,527,149 | — | ↗ |
| 2023-09-22 | McNealey Jennifer Isacoff | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-22 | Lewis-Hall Freda C | Director | — | I | Shares | 0 | 0.00 | — | 516,987 | — | ↗ |
| 2023-09-22 | Heilbron Jack Kendrick | — | M-Exempt | A | Common Stock | 4,060,250 | 0.00 | — | 4,060,250 | — | ↗ |
| 2023-09-22 | Farley Chele Chiavacci | Director | A-Award | A | Warrants | 15,000 | 11.50 | 172.5K | 15,000 | — | ↗ |
| 2023-09-22 | Charles Faith L. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-22 | Bligh James | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-02-03 | Shaolin Capital Management LLC | 10% Owner | — | D | Class A Common Stock | 0 | 0.00 | — | 616,950 | — | ↗ |
| 2022-02-02 | Sragovicz Adam | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-02-02 | Heilbron Jack Kendrick | Director / Officer | — | I | Class A common stock, par value $0.0001 per share | 0 | 0.00 | — | 754,000 | — | ↗ |
| 2022-02-02 | Francis Knuettel II | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-05-03 | TUTTLE RICHARD C | Director | A-Award | A | Option Grant | 2,500 | 8.83 | 22.1K | 27,500 | — | ↗ |
| 2004-05-03 | KALNASY GLENN | Director | A-Award | A | Option Grant | 2,000 | 8.83 | 17.7K | 20,000 | — | ↗ |
| 2004-05-03 | HARRIS MICHAEL F O | Director | A-Award | A | Option Grant | 2,000 | 8.83 | 17.7K | 22,000 | — | ↗ |
| 2004-05-03 | CRESSEY BRYAN C | Director | A-Award | A | Option Grant | 2,500 | 8.83 | 22.1K | 25,500 | — | ↗ |
| 2004-05-03 | BALK LANCE C | Director | A-Award | A | Option Grant | 2,000 | 8.83 | 17.7K | 20,000 | — | ↗ |
| 2004-02-02 | TUTTLE RICHARD C | Director | A-Award | A | Option Grant | 2,500 | 10.42 | 26.1K | 27,500 | — | ↗ |
| 2004-02-02 | KALNASY GLENN | Director | A-Award | A | Option Grant | 2,000 | 10.42 | 20.8K | 20,500 | — | ↗ |
| 2004-02-02 | HARRIS MICHAEL F O | Director | A-Award | A | Option Grant | 2,000 | 10.42 | 20.8K | 22,000 | — | ↗ |
| 2004-02-02 | CRESSEY BRYAN C | Director | A-Award | A | Option Grant | 2,500 | 10.42 | 26.1K | 26,000 | — | ↗ |
| 2004-02-02 | BALK LANCE C | Director | A-Award | A | Option Grant | 2,000 | 10.42 | 20.8K | 20,000 | — | ↗ |
| 2003-12-10 | KUZNIK FERDINAND | Director / Officer | F-InKind | D | Common Stock | 9,480 | 9.59 | 90.9K | 196,171 | — | ↗ |
| 2003-11-03 | TUTTLE RICHARD C | Director | A-Award | A | Option Grant | 2,500 | 10.00 | 25.0K | 25,000 | — | ↗ |
| 2003-11-03 | SHEEHAN PETER | Officer | A-Award | A | Option Grant | 15,700 | 10.00 | 157.0K | 22,700 | — | ↗ |
| 2003-11-03 | MACK IAN | Officer | A-Award | A | Option Grant | 15,700 | 10.00 | 157.0K | 25,700 | — | ↗ |
| 2003-11-03 | KUZNIK FERDINAND | Director / Officer | J-Other | D | Stock Option | 200,000 | 14.25 | 2.85M | 36,000 | — | ↗ |
| 2003-11-03 | KALNASY GLENN | Director | A-Award | A | Option Grant | 2,000 | 10.00 | 20.0K | 18,500 | — | ↗ |
| 2003-11-03 | HARRIS MICHAEL F O | Director | A-Award | A | Option Grant | 2,000 | 10.00 | 20.0K | 20,000 | — | ↗ |
| 2003-11-03 | GRAEBER GEORGE | Director / Officer | A-Award | A | Option Grant | 47,100 | 10.00 | 471.0K | 87,663 | — | ↗ |
| 2003-11-03 | FROMM CHARLES | Officer | A-Award | A | Option Grant | 15,700 | 10.00 | 157.0K | 45,700 | — | ↗ |
| 2003-11-03 | CRESSEY BRYAN C | Director | A-Award | A | Option Grant | 2,500 | 10.00 | 25.0K | 23,500 | — | ↗ |
| 2003-11-03 | CANNY ROBERT | Officer | A-Award | A | Option Grant | 15,700 | 10.00 | 157.0K | 65,150 | — | ↗ |
| 2003-11-03 | CANN WILLIAM | Officer | A-Award | A | Option Grant | 15,700 | 10.00 | 157.0K | 15,700 | — | ↗ |
| 2003-11-03 | CABLE DESIGN TECHNOLOGIES CORP | Officer | A-Award | A | Option Grant | 15,700 | 10.00 | 157.0K | 22,700 | — | ↗ |
| 2003-11-03 | BALK LANCE C | Director | A-Award | A | Option Grant | 2,000 | 10.00 | 20.0K | 18,000 | — | ↗ |
| 2003-10-18 | CRESSEY BRYAN C | Director | G-Gift | D | Common Stock | 40,000 | 0.00 | — | 272,974 | — | ↗ |
| 2003-08-01 | TUTTLE RICHARD C | Director | A-Award | A | Common Stock | 2,325 | 0.00 | — | 30,149 | — | ↗ |
| 2003-08-01 | KALNASY GLENN | Director | A-Award | A | Common Stock | 2,325 | 0.00 | — | 21,808 | — | ↗ |
| 2003-08-01 | HARRIS MICHAEL F O | Director | A-Award | A | Common Stock | 2,325 | 0.00 | — | 0 | — | ↗ |
| 2003-08-01 | CRESSEY BRYAN C | Director | A-Award | A | Common Stock | 2,325 | 0.00 | — | 312,974 | — | ↗ |
| 2003-08-01 | BALK LANCE C | Director | A-Award | A | Common Stock | 2,325 | 0.00 | — | 14,709 | — | ↗ |
Executive team
Top executives
EBIT / Employee
53.03M
Shares Outstanding
176.8K
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Ashish Chand President and Chief Executive Officer | 937.5K | — | 5.28M | — | 1.47M | 354.1K | 8.03M | 65.67% | ↗ |
| 2 | 2024 | Hiran Bhadra Senior Vice President, Strategy and Technology | 512.3K | — | 2.53M | — | 486.9K | 42.6K | 3.57M | 70.79% | ↗ |
| 3 | 2024 | Leah Tate Senior Vice President, Human Resources | 460.0K | — | 2.28M | — | 433.1K | 62.7K | 3.23M | 70.43% | ↗ |
| 4 | 2024 | Jeremy Parks Senior Vice President, Finance, and Chief Financial Officer | 605.0K | — | 1.38M | — | 559.8K | 137.1K | 2.68M | 51.39% | ↗ |
| 5 | 2024 | Brian Anderson Senior Vice President - Legal, General Counsel and Corporate Secretary | 543.3K | — | 927.6K | — | 483.7K | 53.1K | 2.07M | 44.91% | ↗ |
| 6 | 2023 | Ashish Chand President and Chief Executive Officer | 847.1K | — | 9.77M | 950.3K | 823.5K | 369.4K | 12.76M | 84.01% | ↗ |
| 7 | 2023 | Ashish Chand President and Chief Executive Officer | 847.1K | — | 9.77M | 950.3K | 823.5K | 369.4K | 12.76M | 84.01% | ↗ |
| 8 | 2023 | Brian Lieser | 431.4K | — | 1.68M | 174.2K | 292.5K | 703.4K | 3.29M | 56.56% | ↗ |
| 9 | 2023 | Leah Tate Senior Vice President, Human Resources | 439.9K | — | 1.65M | 197.2K | 263.5K | 122.3K | 2.67M | 69.09% | ↗ |
| 10 | 2023 | Jeremy Parks Senior Vice President, Finance, and Chief Financial Officer | 576.5K | — | 1.07M | 315.9K | 342.1K | 137.7K | 2.48M | 56.01% | ↗ |
| 11 | 2023 | Jeremy Parks Senior Vice President, Finance, and Chief Financial Officer | 576.5K | — | 1.07M | 315.9K | 342.1K | 137.7K | 2.48M | 56.01% | ↗ |
| 12 | 2023 | Brian Anderson Senior Vice President - Legal, General Counsel and Corporate Secretary | 517.7K | — | 788.8K | 232.1K | 298.3K | 80.4K | 2.07M | 49.27% | ↗ |
| 13 | 2023 | Brian Anderson Senior Vice President - Legal, General Counsel and Corporate Secretary | 517.7K | — | 788.8K | 232.1K | 298.3K | 80.4K | 2.07M | 49.27% | ↗ |
| 14 | 2023 | Roel Vestjens Former President and Chief Executive Officer | 148.1K | — | — | — | — | 20.7K | 168.9K | 0.00% | ↗ |
| 15 | 2022 | Roel Vestjens Former President and Chief Executive Officer | 946.9K | — | 3.03M | 874.7K | 1.95M | 138.3K | 6.94M | 56.24% | ↗ |
| 16 | 2022 | Ashish Chand President and Chief Executive Officer | 523.9K | — | 880.2K | 254.4K | 877.1K | 396.9K | 2.93M | 38.69% | ↗ |
| 17 | 2022 | Ashish Chand President and Chief Executive Officer | 523.9K | — | 880.2K | 254.4K | 877.1K | 396.9K | 2.93M | 38.69% | ↗ |
| 18 | 2022 | Jeremy Parks Senior Vice President, Finance, and Chief Financial Officer | 530.4K | — | 668.2K | 190.3K | 685.3K | 182.1K | 2.26M | 38.05% | ↗ |
| 19 | 2022 | Jeremy Parks Senior Vice President, Finance, and Chief Financial Officer | 530.4K | — | 668.2K | 190.3K | 685.3K | 182.1K | 2.26M | 38.05% | ↗ |
| 20 | 2022 | Brian Anderson Senior Vice President - Legal, General Counsel and Corporate Secretary | 476.3K | — | 443.5K | 128.1K | 615.4K | 49.6K | 1.71M | 33.37% | ↗ |
| 21 | 2022 | Brian Anderson Senior Vice President - Legal, General Counsel and Corporate Secretary | 476.3K | — | 443.5K | 128.1K | 615.4K | 49.6K | 1.71M | 33.37% | ↗ |
| 22 | 2021 | Roel Vestjens Former President and Chief Executive Officer | 778.1K | — | 3.08M | 895.6K | 2.00M | 83.6K | 6.83M | 58.16% | ↗ |
| 23 | 2021 | Ashish Chand President and Chief Executive Officer | 494.3K | — | 3.72M | 240.1K | 865.2K | 280.8K | 5.60M | 70.73% | ↗ |
| 24 | 2021 | Jeremy Parks Senior Vice President, Finance, and Chief Financial Officer | 459.4K | 271.3K | 1.20M | 200.6K | 735.7K | 119.3K | 2.98M | 46.86% | ↗ |
| 25 | 2021 | Brian Anderson Senior Vice President - Legal, General Counsel and Corporate Secretary | 440.0K | — | 510.7K | 148.6K | 720.7K | 40.1K | 1.89M | 34.81% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| James Bligh | Co-Founder, Chief Financial Officer & Director | 454.8K | male |
| Andrew Regan | Founder, Chief Executive Officer & Director | — | — |
| Joanne Holland | Chief Scientific Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CDT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
